Non-small-cell lung cancer: should histology guide chemotherapy treatment?

被引：1
|
作者：
Bennouna, J. [1 ]
Senellart, H. [1 ]
Douuillar, J. -Y [1 ]
机构：
[1] Ctr Rene Gauducheau, Dept Med Oncol, F-44035 Nantes, France
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷 / 09期
关键词：
1ST-LINE TREATMENT; CISPLATIN;
D O I：
10.1093/annonc/mdp376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1608 / 1609
页数：2
相关论文
共 50 条
  • [1] SHOULD CHEMOTHERAPY BE STANDARD TREATMENT FOR NON-SMALL-CELL LUNG-CANCER
    OLVER, IN
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1986, 144 (13) : 675 - 676
  • [2] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    [J]. LANCET, 2001, 358 (9289): : 1270 - 1271
  • [3] Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer
    Bernstein, ED
    Herbert, SM
    Hanna, NH
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) : 291 - 301
  • [4] CHEMOTHERAPY IN TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER
    SCULIER, JP
    [J]. REVUE DES MALADIES RESPIRATOIRES, 1993, 10 (04) : 287 - 289
  • [5] THE SIGNIFICANCE OF HISTOLOGY IN NON-SMALL-CELL LUNG-CANCER
    ROSENTHAL, SA
    CURRAN, WJ
    [J]. CANCER TREATMENT REVIEWS, 1990, 17 (04) : 409 - 425
  • [6] Preoperative chemotherapy for non-small-cell lung cancer
    Hanna, Gerard G.
    Siva, Shankar
    Plumridge, Nikki
    Solomon, Benjamin
    Ball, David L.
    [J]. LANCET, 2014, 384 (9939): : 232 - 233
  • [7] Afatinib and chemotherapy in non-small-cell lung cancer
    Brower, Vicki
    [J]. LANCET ONCOLOGY, 2016, 17 (02): : E47 - E47
  • [8] Chemotherapy of evolved non-small-cell lung cancer
    Le Chevalier, T
    [J]. EUROCANCER 98, 1998, : 317 - 318
  • [9] Adjuvant chemotherapy of non-small-cell lung cancer
    Rixe, O
    LeChevalier, T
    [J]. ADJUVANT THERAPY OF CANCER VIII, 1997, 8 : 71 - 73
  • [10] Maintenance chemotherapy for non-small-cell lung cancer
    Kim, Young Hak
    Mishima, Michiaki
    [J]. CANCER TREATMENT REVIEWS, 2011, 37 (07) : 505 - 510
12345